Open AccessArterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure
Author(s) -
Kazuhiro Kotoh
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i41.6678
Subject(s) - medicine , fulminant hepatic failure , prothrombin time , ascites , liver transplantation , methylprednisolone , gastroenterology , univariate analysis , liver function tests , liver function , surgery , transplantation , multivariate analysis
To utilize transcatheter arterial steroid injection therapy (TASIT) via the hepatic artery to reduce hepatic macrophage activity in patients with severe acute hepatic failure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom